Form 4: ALX Oncology CFO Peter Garcia Reports Tax-Related Stock Disposal and ESPP Acquisition

Peter Garcia, CFO of ALX Oncology Holdings Inc., reports the disposal of shares to cover tax obligations and acquisition of shares through the employee stock purchase plan.

Summary

• On June 28, 2024, Peter Garcia, the CFO of ALX Oncology Holdings Inc., disposed of 1,789 shares of common stock to cover tax liabilities related to the vesting of restricted stock units (RSUs).
• The shares were sold at a price of $6.03.
• On the same day, Garcia acquired 1,718 shares under the company's employee stock purchase plan (ESPP).
• Following these transactions, Garcia beneficially owns 122,277 shares of ALX Oncology Holdings Inc.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The filing reflects routine transactions related to tax obligations and participation in the employee stock purchase plan, indicating neither strong positive nor negative sentiment.

Positives

• The CFO's participation in the employee stock purchase plan indicates confidence in the company's future.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors to gauge management's sentiment and confidence in the company's prospects.

Stakeholder Impact

• The transactions have a minimal impact on shareholders as they involve a small percentage of the outstanding shares.

Key Dates